Krystal Biotech Total Revenue Over Time
| KRYS Stock | USD 158.23 2.60 1.62% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Krystal Biotech Performance and Krystal Biotech Correlation. Krystal |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Krystal Biotech. If investors know Krystal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Krystal Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.67) | Earnings Share 1.78 | Revenue Per Share 8.49 | Quarterly Revenue Growth 8.799 | Return On Assets 0.0458 |
The market value of Krystal Biotech is measured differently than its book value, which is the value of Krystal that is recorded on the company's balance sheet. Investors also form their own opinion of Krystal Biotech's value that differs from its market value or its book value, called intrinsic value, which is Krystal Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Krystal Biotech's market value can be influenced by many factors that don't directly affect Krystal Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Krystal Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Krystal Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Krystal Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Total Revenue Analysis
Compare Krystal Biotech and related stocks such as Fate Therapeutics, Caribou Biosciences, and Arcus Biosciences Total Revenue Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FATE | 1.2 M | 1.2 M | 2.7 M | 971 K | 0.0 | 2.4 M | 4.4 M | 4.1 M | 4.7 M | 10.7 M | 31.4 M | 55.8 M | 96.3 M | 63.5 M | 66.7 M |
| CRBU | 5.8 M | 5.8 M | 5.8 M | 5.8 M | 5.8 M | 5.8 M | 5.8 M | 5.8 M | 5.8 M | 5.8 M | 12.4 M | 9.6 M | 13.9 M | 34.5 M | 36.2 M |
| RCUS | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.4 M | 8.4 M | 15 M | 77.5 M | 382.9 M | 112 M | 117 M | 98.2 M |
| KPTI | 152 K | 152 K | 634 K | 387 K | 229 K | 250 K | 154 K | 1.6 M | 30.3 M | 40.9 M | 108.1 M | 209.8 M | 157.1 M | 146 M | 153.3 M |
| XFOR | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.5 M | 3 M | 3 M | 0.0 | 0.0 | 0.0 | 0.0 |
| HOOK | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 7.6 M | 11.9 M | 19.6 M | 18.4 M | 14.2 M | 20.1 M | 14.5 M |
Krystal Biotech and related stocks such as Fate Therapeutics, Caribou Biosciences, and Arcus Biosciences Total Revenue description
Total revenue comprises all receipts Krystal Biotech generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.My Equities
My Current Equities and Potential Positions
| Krystal Biotech | KRYS |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Pennsylvania; U.S.A |
| Exchange | NASDAQ Exchange |
USD 158.23
Additional Tools for Krystal Stock Analysis
When running Krystal Biotech's price analysis, check to measure Krystal Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Krystal Biotech is operating at the current time. Most of Krystal Biotech's value examination focuses on studying past and present price action to predict the probability of Krystal Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Krystal Biotech's price. Additionally, you may evaluate how the addition of Krystal Biotech to your portfolios can decrease your overall portfolio volatility.